AC87
I agree with all except 3:
It is the fault of Lynas for not providing enough information via social media, forums, meetings with people before the start of the project. They are paying the price by (still) going through the drawn out legal process which hasn't exactly created confidence. That said, SMSL have a political agenda and it's also bad timing with the next election.
My opinion about the report is that:
How can an objective report be produced without any input from Lynas?
Additionally Lynas will be operating to the conditions of the TOL and has already implemented additional safety measures.
The scientific methodology used is very questionable, inaccurate and biased towards the goals of SMSL which is to resort to fact distortion.
As this report is not objective and has not included any Lynas site visits it hardy rates with any credibility and belongs in a waste bin.
This is of course on provisor that any waste is dissipated into by-products approved by the AELB
- Forums
- ASX - By Stock
- LYC
- cards on the table, nick
LYC
lynas rare earths limited
Add to My Watchlist
0.84%
!
$8.27

cards on the table, nick, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$8.27 |
Change
-0.070(0.84%) |
Mkt cap ! $7.736B |
Open | High | Low | Value | Volume |
$8.30 | $8.35 | $8.14 | $30.78M | 3.743M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 184 | $8.27 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$8.28 | 38197 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 184 | 8.270 |
1 | 3175 | 8.220 |
2 | 2000 | 8.200 |
4 | 6790 | 8.190 |
2 | 5150 | 8.180 |
Price($) | Vol. | No. |
---|---|---|
8.280 | 38197 | 5 |
8.290 | 13003 | 1 |
8.300 | 16408 | 4 |
8.320 | 7490 | 3 |
8.340 | 10002 | 2 |
Last trade - 16.15pm 04/07/2025 (20 minute delay) ? |
Featured News
LYC (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online